The New Eugenics
By Jesse Reynolds,
Z Magazine
| 10. 31. 2002
As this article is being written, delegates from nearly every country are meeting at the United Nations to take the next steps towards an international convention banning human reproductive cloning. Human cloning is the latest, and loudest, in a series of new technologies of human reproductive and genetic manipulation that have – and will – elicit controversy and division in civil society. Additionally, enormous payments to egg “donors” with specific characteristics have been in college newspapers for several years (see “Assisted Reproductive Technologies,” July/August 2002, Z Magazine). Recently, the use of pre-implantation genetic diagnosis, in which embryos are screened for certain genetic characteristics before implantation via in vitro fertilization (IVF), for gender selection or non-disease traits has garnered attention. Soon, we can expect to see public debate over inheritable human genetic engineering, the technology with the greatest potential for social and biological impacts.
Human reproductive cloning is neither far-off science fiction nor banned taboo. The technology is imminent, and several rogue scientists are working to create cloned children. Although more than thirty countries have already passed laws prohibiting reproductive cloning...
Related Articles
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...
By Emily Mullin, Wired | 04.23.2026
A STARTUP OUT of Utah, Paterna Biosciences, says it has successfully grown functional human sperm in a lab and used the sperm to make visibly healthy-looking embryos. The technique could eventually help men with certain types of infertility have biological children...
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...
By Fyodor D. Urnov and Sadik H. Kassim, Nature | 04.21.2026
In February, the US Food and Drug Administration (FDA) proposed a radical rethink of how scientists, physicians and manufacturers develop personalized genetic therapies. The regulator’s suggested introduction of a ‘plausible mechanism pathway’ should increase incentives for drug companies to develop...